Intermolecular Inc (NASDAQ:IMI) Short Interest Update

Intermolecular Inc (NASDAQ:IMI) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 21,200 shares, a drop of 18.8% from the May 30th total of 26,100 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 453,000 shares, the short-interest ratio is currently 0.0 days.

Shares of NASDAQ:IMI remained flat at $$1.17 during trading on Thursday. 19,800 shares of the company’s stock were exchanged, compared to its average volume of 326,037. The business’s fifty day moving average is $1.17. Intermolecular has a 52 week low of $0.88 and a 52 week high of $1.83. The company has a quick ratio of 5.84, a current ratio of 5.84 and a debt-to-equity ratio of 0.38.

Intermolecular (NASDAQ:IMI) last issued its earnings results on Tuesday, May 14th. The semiconductor company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.01. The company had revenue of $6.65 million during the quarter. Intermolecular had a negative net margin of 16.48% and a negative return on equity of 14.36%.

A number of brokerages have issued reports on IMI. Lake Street Capital lowered shares of Intermolecular from a “buy” rating to a “hold” rating in a research note on Monday, May 6th. ValuEngine lowered shares of Zymeworks from a “buy” rating to a “hold” rating in a research note on Saturday, May 18th.

In related news, major shareholder Ventures Ii L.P. Redpoint sold 2,500,000 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $1.17, for a total value of $2,925,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 46.00% of the company’s stock.

An institutional investor recently raised its position in Intermolecular stock. Emancipation Management LLC lifted its holdings in Intermolecular Inc (NASDAQ:IMI) by 102.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 808,200 shares of the semiconductor company’s stock after purchasing an additional 408,200 shares during the period. Intermolecular accounts for about 2.9% of Emancipation Management LLC’s investment portfolio, making the stock its 9th biggest holding. Emancipation Management LLC owned approximately 1.62% of Intermolecular worth $816,000 as of its most recent SEC filing. Institutional investors own 46.31% of the company’s stock.

Intermolecular Company Profile

Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.

Further Reading: Trading Strategy Examples and Plans

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.